Publications by authors named "Victoria T Lee"

Claim this Profile
E
Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett Esophagus Through Methylated DNA Biomarker Triage.
Jayde E Kurland, Sheena B Patel, Richard Englehardt, Seper Dezfoli, Daniel M Tseng, Victoria T Lee

Gastroenterol Hepatol (N Y)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Utility of a Methylated DNA Biomarker Assay on Samples Collected with a Swallowable Capsule-Balloon for Detection of Barrett's Esophagus (BE).
Dan Lister, Andy Fine, Shail Maheshwari, Paul S Bradley, Kimberly Lister, Victoria T Lee

Medicina (Kaunas)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population.
Nicholas J Shaheen, Mohamed O Othman, Jawar Taunk, Kenneth J Chang, Sathya Jaganmohan, Victoria T Lee

Am J Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation of a DNA Methylation Biomarker Test for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma from Samples Collected Using EsoCheck, a Non-Endoscopic Esophageal Cell Collection Device.
Abhisek Ghosal, Suman Verma, Ivy T Le, Victoria T Lee, Brian J deGuzman

Diagnostics (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
Davide Cao, Nicolas Amabile, Mauro Chiarito, Victoria T Lee, Dominick J Angiolillo

Eur Heart J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.
C Michael Gibson, Michael J Mack, Victoria T Lee, David J Schneider, Frank W Sellke

Am Heart J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis